These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19184676)

  • 1. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution.
    Henchoz Y; Bard B; Guillarme D; Carrupt PA; Veuthey JL; Martel S
    Anal Bioanal Chem; 2009 Jun; 394(3):707-29. PubMed ID: 19184676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of determination of biopharmaceutical properties for development candidate selection.
    Yazdanian M
    Curr Protoc Pharmacol; 2013 Mar; Chapter 9():Unit9.17. PubMed ID: 23456615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting oral bioavailability enhancing formulations during drug discovery and development.
    Leucuta SE
    Expert Opin Drug Discov; 2014 Feb; 9(2):139-50. PubMed ID: 24387781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preformulation on drug development.
    Bharate SS; Vishwakarma RA
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1239-57. PubMed ID: 23534681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques.
    Avdeef A; Testa B
    Cell Mol Life Sci; 2002 Oct; 59(10):1681-9. PubMed ID: 12475179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space.
    Ermondi G; Vallaro M; Goetz G; Shalaeva M; Caron G
    Eur J Pharm Sci; 2020 Apr; 146():105274. PubMed ID: 32088315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility and permeability measurement and applications in drug discovery.
    Burton PS; Goodwin JT
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):101-11. PubMed ID: 20053165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research.
    Varma MV; Khandavilli S; Ashokraj Y; Jain A; Dhanikula A; Sood A; Thomas NS; Pillai O; Sharma P; Gandhi R; Agrawal S; Nair V; Panchagnula R
    Curr Drug Metab; 2004 Oct; 5(5):375-88. PubMed ID: 15544432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical predictions of drug absorption in drug discovery and development.
    Stenberg P; Bergström CA; Luthman K; Artursson P
    Clin Pharmacokinet; 2002; 41(11):877-99. PubMed ID: 12190333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.